Genoloam Portfolio | Carefully Curated for Your Healthy Future


  • REGKIRONA, MONOCLONAL ANTIBODY TREATMENT AGAINST COVID-19

    GENOLOAM supplies Regkirona, a monoclonal antibody medicine, by CELLTRION HEALTHCARE CO., LTD. used for treating COVID-19 in adults who do not require supplemental oxygen and who are at increased risk of their disease becoming severe. Regdanvimab has been designed to attach to the spike protein of SARS-CoV-2 consequently blocking cellular entry and SARS-CoV-2 infection. CELLTRION HEALTHCARE CO., LTD. has received drug approval authorization for Regkirona in South Korea and Europe, and for Emergency Use of Authorization (EUA) or Conditional Marketing Authorization (CMA) in Indonesia, Brazil, Peru and Australia.

    Read more about neutralisation data against the Omnicron variant here.

  • V-TUBE BLOOD COLLECTION TUBE

    GENOLOAM supplies V-TUBE, Blood Collection Tube by AB MEDICAL, which has been fully verified in quality by leading university hospitals in South Korea and 10 countries around the world. V-TUBE is a disposable blood collection tube made of plastic with vacuum system to facilitate the predetermined draw volume of blood. V-TUBE contains additives designed to stabilize and preserve the specimen prior to analytical testing.

  • COVID-19 RT PCR REAGENTS

    GENOLOAM provides the world’s fastest and most accurate COVID-19 RT PCR reagents developed by 1DROP INC. 1copy™ Probe, one of 1drop's key technology, is a DNA-RNA hybrid probe that is used with a thermally stable enzyme, RnaseH, suitable for hot start technique to maximize the degradation efficiency. As a result, fluorescence emission is increased significantly which allows detection of DNA and RNA at the level of a single molecule.

  • POCT / DIGITAL PCR

    GENOLOAM supplies Onsite Real Time Service in collaboration with OPTOLANE, which is a Point of Care Service that allows PCR COVID19 inspection without the need for a full-scale lab. This service includes a Digital PCR instrument the size of a lunch box with a sensitivity around 50 times higher as that of a RT-PCR. Higher sensitivity means that the instrument operates larger samples more effectively in terms of uniform mixing reagents, extraction of RNA/DNA and eventual detection of SARS-CoV-2. Therefore, the entire process is completed in about 65 minutes immediately after sample collection, and automatic reporting is completed online.

  • RNA EXTRACTION SYSTEM

    GENOLOAM supplies precision equipment and reagents for RNA extraction essential for all diagnostic tests, not just for detection of COVID-19. GENOLUTION Nextractor ® NX-48S is an automated DNA/RNA isolation system that conducts rapid DNA/RNA isolation from a variety of samples using magnetic beads. The Automated Extractor saves time and effort by providing a platform and reagents capable of handling 48 samples per cycle in less than 20 minutes through quick and easy operation.

  • HPV (HUMAN PAPILLOMAVIRUS)

    In the current era of research on various methods for early detection, tracking, and observation of HPV (Human Papillomavirus), known as the main cause of cervical cancer, GENOLOAM provides an early detection and follow-up method for HPV using NGS (Next Generation Sequencing) as one of the more fundamental and convenient screening methods.

 GENOLOAM, together with our leading healthcare partners in South Korea and EU, is currently developing Liquid Biopsy for early detection of cancer, NIPT (Non-Invasive Primary Test) for early diagnosis of fetuses and IT platforms based on telemedicine. These services are scheduled to be commercialized in early 2023.

If you want to learn more about our current and upcoming products and services, contact us today.